Search research articles
Contact Us
Filters
Showing results (41-50 of 96) with videos related to
Page
of 10
Sort By:
Cancer
|
July 25, 2007
Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience
Shaheenah Dawood, Ana M Gonzalez-Angulo, Florentia Peintinger, et al.
Breast Cancer Research and Treatment
|
July 16, 2009
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines
Cornelia Liedtke, Jing Wang, Attila Tordai, et al.
Cancer
|
May 4, 2000
Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration
D C Chhieng, G Fernandez, J F Cangiarella, et al.
Plos Medicine
|
December 14, 2016
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
Tingting Jiang, Weiwei Shi, Vikram B Wali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2008
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy
M Zoubir, M C Mathieu, C Mazouni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
A Sheri, I E Smith, S R Johnston, et al.
Cancer Letters
|
May 8, 2025
ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy
Shuying Liu, Huiqin Chen, Mihai Gagea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 9, 2008
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease
Julie R Gralow, Harold J Burstein, William Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment
W F Symmans, M D Volm, R L Shapiro, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 96) with videos related to
Sort By:
Page
of 10
Cancer
|
July 25, 2007
Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience
Shaheenah Dawood, Ana M Gonzalez-Angulo, Florentia Peintinger, et al.
Breast Cancer Research and Treatment
|
July 16, 2009
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines
Cornelia Liedtke, Jing Wang, Attila Tordai, et al.
Cancer
|
May 4, 2000
Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration
D C Chhieng, G Fernandez, J F Cangiarella, et al.
Plos Medicine
|
December 14, 2016
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
Tingting Jiang, Weiwei Shi, Vikram B Wali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2008
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy
M Zoubir, M C Mathieu, C Mazouni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
A Sheri, I E Smith, S R Johnston, et al.
Cancer Letters
|
May 8, 2025
ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy
Shuying Liu, Huiqin Chen, Mihai Gagea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 9, 2008
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease
Julie R Gralow, Harold J Burstein, William Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment
W F Symmans, M D Volm, R L Shapiro, et al.
Page
of 10